JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB142091

TGR5 Receptor Agonist, TGR5 G-protein coupled receptor agonist

Be the first to review this product! Submit a review

|

(2 Publications)

MW 361.2 Da, Purity >99%. Potent, selective TGR5 G-protein coupled receptor agonist (pEC50 = 6.8). Increases glucagon-like peptide-1 (GLP-1) secretion from primary intestinal cells. Cell-permeable. Active in vivo.
1 Images
Chemical Structure - TGR5 Receptor Agonist, TGR5 G-protein coupled receptor agonist (AB142091)
  • Chemical Structure

Lab

Chemical Structure - TGR5 Receptor Agonist, TGR5 G-protein coupled receptor agonist (AB142091)

2D chemical structure image of ab142091, TGR5 Receptor Agonist, TGR5 G-protein coupled receptor agonist

Key facts

CAS number

1197300-24-5

Purity

>99%

Form

Solid

form

Molecular weight

361.2 Da

Molecular formula

C<sub>1</sub><sub>8</sub>H<sub>1</sub><sub>4</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub>

PubChem

44605616

Nature

Synthetic

Solubility

Soluble in ethanol to 100 mM

Soluble in DMSO to 100 mM

Biochemical name

TGR5 Receptor Agonist

Biological description

Potent, selective TGR5 G-protein coupled receptor agonist (pEC50 = 6.8). Increases glucagon-like peptide-1 (GLP-1) secretion from primary intestinal cells. Cell-permeable. Active in vivo.

Canonical smiles

CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)N(C)C3=CC=C(C=C3)Cl

InChi

InChI=1S/C18H14Cl2N2O2/c1-11-16(17(21-24-11)14-5-3-4-6-15(14)20)18(23)22(2)13-9-7-12(19)8-10-13/h3-10H,1-2H3

InChiKey

IGRCWJPBLWGNPX-UHFFFAOYSA-N

IUPAC Name

3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-dimethyl-1,2-oxazole-4-carboxamide

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GPCR TGR5 also known as G protein-coupled bile acid receptor 1 (GPBAR1) is a member of the GPCR superfamily. This receptor weighs approximately 35 kDa and is expressed in various tissues including liver intestine brown adipose tissue and macrophages. It functions as a membrane receptor that binds bile acids which activates downstream signaling pathways influencing metabolic processes.
Biological function summary

GPCR TGR5 plays a role in energy metabolism and the immune response. It does not form part of a larger receptor complex but interacts with different proteins to mediate its effects. Upon activation by bile acids TGR5 stimulates the production of cyclic AMP (cAMP) and regulates the release of various cytokines influencing metabolic rate and promoting anti-inflammatory effects.

Pathways

GPCR TGR5 links to the cAMP signaling pathway and plays a role in the brown adipose tissue activation pathway. It is closely related to proteins like adenylate cyclase which it activates to increase cAMP levels and potentially interacts with nuclear receptors modifying gene expression linked to energy homeostasis and inflammation control.

GPCR TGR5 associates with metabolic disorders such as obesity and type 2 diabetes. Its role in regulating energy expenditure makes it a target for combating obesity where it influences pathways involving protein partners like adenylate cyclase. Additionally its involvement in controlling inflammation connects it to diseases involving immune dysregulation offering potential pathways for therapeutic interventions.

Product protocols

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:4990 PubMed40442088

2025

Pharmacological and physiological activation of TGR5 in the NTS lowers food intake by enhancing leptin-STAT3 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Kyla Bruce,Song-Yang Zhang,Ameth N Garrido,Melissa T Wang,Tomás P Bachor,Pengcheng Wang,Allison W Xu,Zeyu Yang,Tony K T Lam

Infection and immunity 85: PubMed28348052

2017

Bile Acid Administration Elicits an Intestinal Antimicrobial Program and Reduces the Bacterial Burden in Two Mouse Models of Enteric Infection.

Applications

Unspecified application

Species

Unspecified reactive species

Sarah Tremblay,Guillaume Romain,Mélisange Roux,Xi-Lin Chen,Kirsty Brown,Deanna L Gibson,Sheela Ramanathan,Alfredo Menendez
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com